How Latham was paid
$1.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Other | Total |
|---|---|---|---|---|---|
| Joel LathamChief Executive Officer | $656,464 | $297,689 | — | $173,586 | $1,127,739 |
| Joseph SwanChief Financial Officer | $150,650 | $30,130 | — | $20,413 | $201,193 |
| Luigi M. Barbato, M.D.Chief Medical Officer | $264,063 | — | $233,104 | — | $497,167 |
What changed and why
- $1.1M$1,127,739 was Joel Latham’s 2025 total compensation, down from $6,216,082 in 2024.
- $298K$297,689 was Latham’s 2025 cash bonus, and he received $395,000 in September 2025.
- $233K$233,104 was Luigi Barbato’s 2025 stock-award compensation after joining as chief medical officer in October 2024.
- 20%20% was the annual target bonus opportunity for Swan and Barbato under their employment agreements.
- 50%50% was Latham’s annual target bonus opportunity as a percentage of base salary.
- Regulatory, clinical, development, operational and financing objectives determined 2025 performance bonuses.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.